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Solitary fibrous tumors (SFTs) of the spine are exceedingly rare tumors of mesenchymal
origin. Most spinal SFTs arise from the thoracic spine, followed by cervical spine, and last
lumbar spine with only 6 cases reported in literature. SFTs represent a wide range of
neoplasms, ranging from benign to malignant. These tumors can develop a late recurrence,
even after a decade or more of initial presentation, requiring long-term follow-up. We
present a case of recurrent SFT of the lumbar spine with vertebral body involvement,
presenting more than a decade after initial resection. It was initially misdiagnosed as a
paraganglioma. To the best of our knowledge, there have been only 3 previous cases
reporting SFT with vertebral body involvement.
Published by Elsevier Inc. on behalf of under copyright license from the University of
Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Solitary fibrous tumors (SFTs), previously grouped together
with hemangiopericytomas, are rare soft-tissue tumors
mostly occurring in the thoracic region but can arise any-
where in the body [1e3]. Spinal SFTs are a rare entity with the
most common location being thoracic spine followed by
cervical and lastly lumbosacral spine [4e10]. SFTs are
mesenchymal in origin as proved by immunohistochemistry;
however, histologically, these appear as haphazardly ar-
ranged spindle cells with interspersed hypocellular collage-
nous areas. A histopathologic differential diagnosis for SFTlared that no competing i
(Z. Farooq).
alf of under copyright lic
://creativecommons.org/lincludes sarcomatoid carcinoma that displays additional nu-
clear atypia and a malignant glandular component. Synovial
sarcoma is another differential that demonstrates more
primitive and hyperchromatic chromatin with increased
mitotic activity. CD34 is usually negative in synovial sarcoma
[11]. Mesenchymal chondrosarcoma may show a similar
vascular pattern, however, would demonstrate cartilaginous
growth [11]. Nuclear labeling for STAT6 is highly specific for
SFT and is related to the NAB2-STAT6 gene fusion [11].
Most of these lesions have a benign course, but local
recurrence and metastasis have been reported in a number of
cases [12]. In terms of malignant potential, pleural SFTs arenterests exist.
ense from the University of Washington. This is an open access
icenses/by-nc-nd/4.0/).
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tumors [13]. We present a case of spinal SFT involving lumbar
vertebral body. It was previously misdiagnosed as a para-
ganglioma and only appropriately characterized after
recurrence.Case report
A 73-year-old man with history of treated prostate cancer,
presented originally with complaint of left lower-extremity
weakness and numbness that was progressively getting
worse over the last few years. Additional complaints included
chronic low back pain and constipation.
Physical examination revealed diminished sensation along
the left groin, anterior thigh and calf. The strength in right
lower extremity was reported as 4 of 5, and left lower
extremity was reported as 3 of 5. The patient was originally
diagnosed in 1992, with a lumbar spinal tumor known to be a
paraganglioma, for which he had undergone surgical resec-
tion at the time, followed by combination intensity-
modulated radiation therapy and proton therapy in 2002.
The patient was followed by a physician from an outside
facility since 2012, and in 2015, he was referred to our facility
for a second opinion, as the lumbar lesion was thought to be
increasing in the interim (Figs 1A and B). He presented to our
facility with the above mentioned chief complaint, where
computed tomography (CT) imaging displayed expansion of
canal by isodense soft-tissue mass with accompanying
osseous destruction (Figs 2A-D). Further evaluation with a
magnetic resonance imaging (MRI) scan demonstrated the
mass to be hypointense on T1-weighted and T2-weighted
imaging, with T1 postcontrast imaging showing homoge-
nous enhancement of the lesion (Figs 3A-C).
The patient then underwent anterior L1 corpectomy, dur-
otomy repair, anterior T11-L2 fusion, posterior T11-L3 fusion
for removal of lesion at the L1 vertebral level. The mass was
approximately 6.9  6.5  2.5 cm in size. Pathology specimensFig. 1 e (A) T1 sagittal precontrast image from a study in 2014 de
osseous destruction at L1 vertebral level. (B) T1 sagittal postcon
heterogeneous enhancement of the lesion at L1 vertebral level.were obtained from the L1 vertebral body and the adjacent
dura. These specimens demonstrated spindle cell lesion with
interspersed collagen and small vascular spaces (Fig. 4). A
synovial sarcoma was ruled out, as a positive CD34 stain was
observed (Fig. 5). Nonetheless, a confirmatory histopathologic
diagnosis of SFT was further displayed by a positive STAT6
stain (Fig. 6).Discussion
SFT is a soft-tissue neoplasm of mesenchymal origin. These
rare lesions usually arise from an intrathoracic location;
however, literature has reported extrathoracic locations as
well, such as spinal cord, head and neck, extremities,
abdominal and pelvic organs, and retroperitoneum [14e16].
To the best of our knowledge, there have been only 3 reported
cases of SFT resulting in vertebral body involvement [5,17,18].
SFTs have been previously grouped together with heman-
giopericytomas. As pleura was the most common site of
involvement, the neoplasm was initially thought to be meso-
thelial in origin; however, further characterization with
immunohistochemical stains as well as its ubiquitous pres-
ence resolved the matter and determined the mesenchymal
origin of the tumor [19]. SFT can present in a wide range of age
groups with peak incidence noted in fifth to seventh decade of
life, with no gender predilection [20,21]. The histology is usu-
ally comprised of collagenous matrix with arrays of haphaz-
ardly arranged, uniform elongated spindle cells [21].
Immunohistochemistry displays positive stain for CD34 in
SFTs [21]. With the identification of CD34 and STAT6 in SFTs,
the diagnosis has become somewhat less elusive than it used
to be.
Furthermore, radiographic features on plain films demon-
strate erosive soft-tissuemass in spinal column or appendage.
A contrast-enhanced CT will show a smooth, well circum-
scribed homogenously enhancing soft-tissue mass with
possible erosion of adjacent osseous structures. Nomonstrates hypointense lesion with irregular margins and
trast image from a study in 2014 demonstrates mild
Fig. 2 e (A) Axial CT image demonstrates isodense soft-tissue mass with adjacent osseous destruction involving the L1
vertebral body. (B) Axial CT image in soft tissue window again demonstrates the soft-tissue mass with extension in to the
spinal canal and adjacent osseous destruction. (C) Sagittal CT image demonstrates soft-tissue mass with accompanying
osseous destruction with extension of themass into the spinal canal at L1 vertebral level. (D) Sagittal CT image in soft-tissue
window again demonstrates soft-tissue mass with accompanying osseous destruction with extension of the mass into the
spinal canal at L1 vertebral level.
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CT. However, larger tumors have areas of necrosis repre-
sented by hypoattenuated areas on CT [22]. MRI findings of
SFT demonstrate a hypointense multilobular mass expanding
into or eroding adjacent bone on T1 and a hypointense mass
on T2-weighted imaging. T1 postcontrast images show vivid,
homogenous enhancement of the mass [23,24]. Short T1
inversion recovery imaging would demonstrate osseous in-
vasion as a hyperintense component with the normalmarrow
being suppressed. However, variable characteristics on MRI
have been reported for areas of necrosis and hemorrhage
within the mass; with increased signal intensity on
T1-weighted imaging suggestive of subacute hemorrhage,
whereas heterogeneous pattern of enhancement onpostcontrast images with increased signal intensity on
T2-weighted imaging is more suggestive of necrotic foci [24].
In addition, positron emission tomography scan may be
helpful in differentiating benign from malignant SFT and
identifying anymetastasis present at the time of presentation
[24]. Differential diagnosis for an SFT based on radiographic
presentation includes a meningioma, schwannoma, chor-
doma, aggressive hemangioma, vascular metastases, and
rarely an angiosarcoma. A meningioma would usually be well
circumscribed, nonerosive, with calcifications and would be
more common in women [25]. As for a schwannoma, one
would visualize an avidly enhancing mass in the spinal canal
with neural foramen involvement leading to bony remodeling
and foraminal enlargement. In addition, a schwannoma
Fig. 3 e (A) Axial precontrast T1-weighted sequences demonstrate L1 epidural soft-tissue mass eroding the adjacent bone
with the mass appearing hypointense on T1-weighted sequences. (B) Axial T2-weighted sequences show the soft-tissue
mass appearing profoundly hypointense with redemonstration of osseous destruction at the L1 vertebral level. (C) Axial
postcontrast T1 images show homogeneous vivid enhancement of the soft-tissue mass involving the L1 vertebral level.
R a d i o l o g y C a s e R e p o r t s 1 1 ( 2 0 1 6 ) 4 5 0e4 5 5 453would be hyperintense on T2 [26]. Furthermore, a chordoma is
most commonly seen in the sacrum with its presentation as
an extraosseous and/or epidural soft-tissue mass with theFig. 4 e Spindle cell lesion with interspersed collagen and
small vascular spaces.destructive process centered in the bone [27]. An aggressive
hemangioma shows thickened vertical trabeculae within area
of circumscribed osteolysis, with the lesion demonstratingFig. 5 e Positive CD34 stain.
Fig. 6 e Positive STAT6 staining.
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vertebral soft-tissue mass [28]. Renal cell and thyroid carci-
nomas are known for causing vascular metastases; however,
these are usually centered in the cancellous bone with
involvement of the posterior elements of the vertebral body
[29].
SFT represents a diverse group of neoplasms in terms of its
malignant potential; ranging from completely benign tumor
with complete cure on resection to malignant neoplasm with
recurrence and even distant metastasis [30]. A number of in-
dicators have been defined to characterize SFT into typical
(with benign outlook) or malignant neoplasm. High mitotic
index, nuclear pleomorphism, necrosis, and large tumor size
have all been associated with a more malignant course;
however, no clear correlation between histologic character-
istics and clinical outcome has been established [31]. A study
focusing on delayed recurrent SFT demonstrated that 5 of 12
cases of recurrence were initially diagnosed with a typical
SFT; thus suggesting a need for prolonged follow-up evenwith
histologically benign disease initially [26]. SFTs are known for
a late recurrence. A study aiming to determine outcomes for
late recurrence reported a median time of 12 years to the first
recurrence [26]. Our case corroborates this finding as well, as
our patient presentedwith symptoms after almost a decade of
initial resection. The most common pattern of recurrence is
local, but a substantial percentage of patients can present
with distant metastasis, so a history of SFT in a patient pre-
senting with a mass in an unrelated location should still
prompt consideration for recurrence even after a decade or
more of initial diagnosis.
This case also emphasizes the importance of considering
diagnosis other than metastatic prostate cancer in patients
with vertebral body involvement and back pain.With prostate
cancer being one of themore common causes of symptoms in
this scenario, additional diagnostic considerations can be
overlooked.Conclusions
SFTsof the spine, especially lumbar spine, are exceedingly rare
withonly a fewpublishedcases. Spinal SFTs canpresentwithalate recurrence causing local invasion and destruction of
vertebral body even after a decade or more of initial resection.
So in a patient with history of SFT, possibility of recurrence
shouldalwaysbekept inmind.Furthermore,prolonged follow-
up is recommended once a diagnosis of SFT is established.r e f e r e n c e s
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